AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34429151 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control
Number of subjects: 51
Study 32229173 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodynamic optimisation using photoplethysmography (interventional group)
Number of subjects: 160
Study 32229173 — intervention group
Group type: COMPARATOR
Intervention: Intermittent mean arterial pressure (control group)
Number of subjects: 160
Study 35504197 — intervention group
Group type: EXPERIMENTAL
Intervention: Porous metaphyseal cones 3D‐printed of titanium
Number of subjects: 0
Study 33766533 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy radiotherapy (PMRT) or supraclavicular radiation therapy (SCV RT)
Number of subjects: 185
Study 33766533 — intervention group
Group type: COMPARATOR
Intervention: No PMRT or SCV RT
Number of subjects: 185
Study 35462880 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete nutrition drink with retrograded starch
Number of subjects: 18
Study 32753064 — intervention group
Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch 130/0.4 (colloid group)
Number of subjects: 60
Study 32753064 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution (crystalloid group)
Number of subjects: 60
Study 34120363 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease supplementation at 500 g/ton in low protein diet (29% CP)
Number of subjects: 360
Study 34120363 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease supplementation at 250 g/ton in normal protein diet (30% CP)
Number of subjects: 360
Study 34120363 — intervention group
Group type: COMPARATOR
Intervention: Control -ve (low protein diet, 29% CP without protease)
Number of subjects: 360
Study 34120363 — intervention group
Group type: COMPARATOR
Intervention: Control +ve (normal protein diet, 30% CP without protease)
Number of subjects: 360
Study 34120363 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease supplementation
Number of subjects: 360
Study 34301320 — intervention group
Group type: EXPERIMENTAL
Intervention: omega-3 fatty acids (W-3 FAs)
Number of subjects: 80
Study 34301320 — intervention group
Group type: EXPERIMENTAL
Intervention: combined omega-3 and nanocurcumin
Number of subjects: 80
Study 34301320 — intervention group
Group type: COMPARATOR
Intervention: nanocurcumin
Number of subjects: 80
Study 34301320 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 80
Study 35642288 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-week basketball training programme (3 times per week, 60 min per session)
Number of subjects: 22
Study 35642288 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained daily activities without special physical training)
Number of subjects: 22
Study 34103345 — intervention group
Group type: EXPERIMENTAL
Intervention: Restarting antiplatelet therapy
Number of subjects: 537
Study 34103345 — intervention group
Group type: COMPARATOR
Intervention: Avoiding antiplatelet therapy
Number of subjects: 537
Study 34103345 — intervention group
Group type: EXPERIMENTAL
Intervention: DWI+ lesion presence
Number of subjects: 537
Study 33139664 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Arcade prototype multidomain intervention based on physical and cognitive training using gamification technologies
Number of subjects: 40
Study 33139664 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Arcade prototype multidomain intervention
Number of subjects: 40
Study 36030965 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI + atrial LVA ablation
Number of subjects: 0
Study 36030965 — intervention group
Group type: COMPARATOR
Intervention: PVI alone
Number of subjects: 0
Study 32769519 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 units of abobotulinumtoxinA
Number of subjects: 50
Study 32769519 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 units of abobotulinumtoxinA
Number of subjects: 50
Study 32769519 — intervention group
Group type: COMPARATOR
Intervention: 0 units of abobotulinumtoxinA (placebo)
Number of subjects: 50
Study 34039013 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide (240 mg/day) plus continuous androgen deprivation therapy (ADT)
Number of subjects: 0
Study 34039013 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus continuous androgen deprivation therapy (ADT)
Number of subjects: 0
Study 35417910 — intervention group
Group type: EXPERIMENTAL
Intervention: SWiM‐C
Number of subjects: 388
Study 35417910 — intervention group
Group type: COMPARATOR
Intervention: Standard advice
Number of subjects: 388
Study 34620907 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-adhesion agent Collabarrier
Number of subjects: 100
Study 34620907 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no anti-adhesion agent)
Number of subjects: 100
Study 32053937 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming group
Number of subjects: 15
Study 32053937 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical training group
Number of subjects: 15
Study 32053937 — intervention group
Group type: COMPARATOR
Intervention: No training group (control)
Number of subjects: 15
Study 35216853 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention message targeting the fundamental motive of kin care
Number of subjects: 969
Study 35216853 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention message targeting the fundamental motive of disease avoidance
Number of subjects: 969
Study 35216853 — intervention group
Group type: COMPARATOR
Intervention: Control message
Number of subjects: 969
Study 34887317 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol/budesonide (180/160 µg or 180/80 µg, two actuations of 90/80 µg or 90/40 µg)
Number of subjects: 3100
Study 34887317 — intervention group
Group type: COMPARATOR
Intervention: Albuterol (180 µg, two actuations of 90 µg)
Number of subjects: 3100
Study 35191512 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodalumab 140 mg
Number of subjects: 4464
Study 35191512 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodalumab 210 mg
Number of subjects: 4464
Study 35191512 — intervention group
Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 4464
Study 35191512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4464
Study 33158230 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT
Number of subjects: 750
Study 33158230 — intervention group
Group type: COMPARATOR
Intervention: HHC
Number of subjects: 750
Study 33158230 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT with NRT
Number of subjects: 750
Study 33205741 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine (radiation-attenuated, 2.7 × 10^6 PfSPZ, three doses at 8-week intervals)
Number of subjects: 28
Study 33205741 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac (infectious, 1.0 × 10^5 PfSPZ, three doses at 4-week intervals)
Number of subjects: 28
Study 33205741 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 28
Study 33205741 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac
Number of subjects: 28
Study 33205741 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine
Number of subjects: 28
Study 33222559 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4-mg
Number of subjects: 0
Study 33222559 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2-mg
Number of subjects: 0
Study 33222559 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 1-mg
Number of subjects: 0
Study 33222559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33587407 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks Exclusive Enteral Nutrition (EEN) followed by 6 weeks 25% Partial Enteral Nutrition (PEN)
Number of subjects: 29
Study 33587407 — intervention group
Group type: COMPARATOR
Intervention: 6 weeks 50% PEN with CD exclusion diet followed by 6 weeks 25% PEN with exclusion diet
Number of subjects: 29
Study 33587407 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA scans performed at diagnosis
Number of subjects: 29
Study 32341595 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid glucocorticoid tapering
Number of subjects: 0
Study 32341595 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucocorticoid tapering
Number of subjects: 0
Study 34266323 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive, domiciliary, mobile application-guided and tele-monitored cardiac rehabilitation program (n=49)
Number of subjects: 100
Study 34266323 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation treatment (control group) (n=48)
Number of subjects: 100
Study 34263971 — intervention group
Group type: EXPERIMENTAL
Intervention: Licogliflozin 50 mg TID
Number of subjects: 0
Study 33136923 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole (1, 2, or 3 mg)
Number of subjects: 0
Study 33136923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33136923 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole (OLE, flexible-dose 0.5-3 mg/d)
Number of subjects: 0
Study 33136923 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 0
Study 35844045 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide-pulse NMES (WP)
Number of subjects: 16
Study 35844045 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow-pulse NMES (NP)
Number of subjects: 16
Study 35844045 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide-pulse NMES with tendon vibration (WP+VIB)
Number of subjects: 16
Study 35844045 — intervention group
Group type: COMPARATOR
Intervention: All NMES conditions
Number of subjects: 16
Study 35496721 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization exercises (SEs) combined with pelvic floor muscle (PFM) exercises
Number of subjects: 48
Study 35496721 — intervention group
Group type: COMPARATOR
Intervention: Stabilization exercises (SEs) alone
Number of subjects: 48
Study 35776517 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 pandemic impact on caregivers
Number of subjects: 17
Study 32233639 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic soft channel puncture and drainage
Number of subjects: 60
Study 32233639 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment with small bone window hematoma removal
Number of subjects: 60
Study 35815055 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite skin graft
Number of subjects: 78
Study 35815055 — intervention group
Group type: COMPARATOR
Intervention: Autologous skin graft
Number of subjects: 78
Study 35815055 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI imaging
Number of subjects: 78
Study 33357499 — intervention group
Group type: EXPERIMENTAL
Intervention: Benralizumab (30 mg every 8 weeks, first three doses given 4 weeks apart)
Number of subjects: 656
Study 33357499 — intervention group
Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 656
Study 33357499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 656
Study 35294812 — intervention group
Group type: EXPERIMENTAL
Intervention: donidalorsen (80 mg)
Number of subjects: 20
Study 35294812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33794517 — intervention group
Group type: EXPERIMENTAL
Intervention: AI model using modified Mask R-CNN algorithm
Number of subjects: 13228
Study 33794517 — intervention group
Group type: COMPARATOR
Intervention: Three attending orthopedic doctors
Number of subjects: 13228
Study 33794517 — intervention group
Group type: EXPERIMENTAL
Intervention: AI model
Number of subjects: 13228
Study 33129289 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-Curcumin 80 mg
Number of subjects: 60
Study 33129289 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone 10 mg
Number of subjects: 60
Study 33766186 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy (PCIT)
Number of subjects: 120
Study 33568279 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid administration at induction for hemiarthroplasty
Number of subjects: 51
Study 33568279 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid administration at induction for intramedullary nail fixation
Number of subjects: 51
Study 33568279 — intervention group
Group type: COMPARATOR
Intervention: Control group for hemiarthroplasty (no TXA)
Number of subjects: 51
Study 33568279 — intervention group
Group type: COMPARATOR
Intervention: Control group for intramedullary nail fixation (no TXA)
Number of subjects: 51
Study 36356829 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 69
Study 36356829 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose nVNS
Number of subjects: 69
Study 36356829 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose nVNS
Number of subjects: 69
Study 33894738 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia (MUA)
Number of subjects: 360
Study 33894738 — intervention group
Group type: COMPARATOR
Intervention: Lysis of adhesions (LOA)
Number of subjects: 360
Study 32276257 — intervention group
Group type: EXPERIMENTAL
Intervention: Occipital anchors
Number of subjects: 14
Study 32276257 — intervention group
Group type: COMPARATOR
Intervention: Occipital plate and screws
Number of subjects: 14
Study 36252858 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralized digital workflow (c‐DW)
Number of subjects: 59
Study 36252858 — intervention group
Group type: COMPARATOR
Intervention: Laboratory digital workflow (l‐DW)
Number of subjects: 59
Study 36252858 — intervention group
Group type: EXPERIMENTAL
Intervention: Both workflows
Number of subjects: 59
Study 32778471 — intervention group
Group type: EXPERIMENTAL
Intervention: High Phosphatemic Index (PI) test meals
Number of subjects: 30
Study 32778471 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Phosphatemic Index (PI) test meals
Number of subjects: 30
Study 32778471 — intervention group
Group type: COMPARATOR
Intervention: Control meals
Number of subjects: 30
Study 35103074 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC)
Number of subjects: 280
Study 33306558 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative video-based opioid education
Number of subjects: 130
Study 33306558 — intervention group
Group type: COMPARATOR
Intervention: Standard of care for pain management education (Control)
Number of subjects: 130
Study 32282525 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum pelvic floor physical therapy (PFPT)
Number of subjects: 50
Study 32282525 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study 35983532 — intervention group
Group type: EXPERIMENTAL
Intervention: CPL NPWTi
Number of subjects: 60
Study 35983532 — intervention group
Group type: COMPARATOR
Intervention: Normal saline NPWTi
Number of subjects: 60
Study 34698464 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy with miniature bian needle
Number of subjects: 74
Study 34698464 — intervention group
Group type: COMPARATOR
Intervention: Proper physical exercise
Number of subjects: 74
Study 33380704 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (8 mg/day)
Number of subjects: 45
Study 33380704 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 45
Study 33380704 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional therapy + placebo)
Number of subjects: 45
Study 35771353 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b1 mRNA vaccine (10 µg dose)
Number of subjects: 141
Study 35771353 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b1 mRNA vaccine (30 µg dose)
Number of subjects: 141
Study 35771353 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b1 mRNA vaccine (in older participants)
Number of subjects: 141
Study 35771353 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b1 mRNA vaccine
Number of subjects: 141
Study 34065775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile diabetes management
Number of subjects: 181
Study 34065775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile diabetes management with HCP feedback
Number of subjects: 181
Study 34065775 — intervention group
Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 181
Study 32821494 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Wave Transscleral Cyclophotocoagulation (CW‐TCP)
Number of subjects: 12
Study 32821494 — intervention group
Group type: EXPERIMENTAL
Intervention: Micropulse Transscleral Cyclophotocoagulation (MP‐TCP)
Number of subjects: 12
Study 32821494 — intervention group
Group type: COMPARATOR
Intervention: Nontreated control
Number of subjects: 12
Study 35552938 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery with neutral argon plasma (PlasmaJet)
Number of subjects: 327
Study 35552938 — intervention group
Group type: COMPARATOR
Intervention: Without PlasmaJet (control group)
Number of subjects: 327
Study 34335853 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm water and ginger (GI)
Number of subjects: 17
Study 34335853 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm water and mustard (MU)
Number of subjects: 17
Study 34335853 — intervention group
Group type: COMPARATOR
Intervention: Warm water only (WA)
Number of subjects: 17
Study 34335853 — intervention group
Group type: EXPERIMENTAL
Intervention: All three conditions (GI, MU, WA)
Number of subjects: 17
Study 35234732 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-tong splint
Number of subjects: 89
Study 35234732 — intervention group
Group type: COMPARATOR
Intervention: Clamshell splint
Number of subjects: 89
Study 35234732 — intervention group
Group type: EXPERIMENTAL
Intervention: Both splint types
Number of subjects: 89
Study 32926823 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 0
Study 32926823 — intervention group
Group type: COMPARATOR
Intervention: VKAs
Number of subjects: 0
Study 32926823 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 32926823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35314431 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-antibiotic treatment options
Number of subjects: 26
Study 35314431 — intervention group
Group type: EXPERIMENTAL
Intervention: Postponing antibiotic treatment by up to 3 days
Number of subjects: 26
Study 34597318 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 112
Study 34597318 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft occlusive splint therapy (OST)
Number of subjects: 112
Study 34597318 — intervention group
Group type: COMPARATOR
Intervention: Control (waitlist group)
Number of subjects: 112
Study 34597318 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 112
Study 32390725 — intervention group
Group type: EXPERIMENTAL
Intervention: 2/0/X tempo
Number of subjects: 21
Study 32390725 — intervention group
Group type: EXPERIMENTAL
Intervention: 4/0/X tempo
Number of subjects: 21
Study 32390725 — intervention group
Group type: EXPERIMENTAL
Intervention: 6/0/X tempo
Number of subjects: 21
Study 33128187 — intervention group
Group type: EXPERIMENTAL
Intervention: LA strain (LAS) and strain rate (LASR) assessment using Feature Tracking software (QStrain v2.0)
Number of subjects: 60
Study 33128187 — intervention group
Group type: EXPERIMENTAL
Intervention: LA volumes (LAV) and emptying fraction (LAEF) calculated using the biplane area length method (QMass v8.1)
Number of subjects: 60
Study 33128187 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra- and inter-observer variability assessment
Number of subjects: 60
Study 32649365 — intervention group
Group type: EXPERIMENTAL
Intervention: Ala-Gln at 12g/day
Number of subjects: 140
Study 32649365 — intervention group
Group type: EXPERIMENTAL
Intervention: Ala-Gln at 3g/day
Number of subjects: 140
Study 32649365 — intervention group
Group type: EXPERIMENTAL
Intervention: Ala-Gln at 6g/day
Number of subjects: 140
Study 32649365 — intervention group
Group type: EXPERIMENTAL
Intervention: Ala-Gln at 3g/day, 6g/day, and 12g/day
Number of subjects: 140
Study 32649365 — intervention group
Group type: EXPERIMENTAL
Intervention: Ala-Gln
Number of subjects: 140
Study 32649365 — intervention group
Group type: COMPARATOR
Intervention: Gly placebo at 12.5g/day
Number of subjects: 140
Study 33303191 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressed lithium disilicate (LD) crowns
Number of subjects: 62
Study 33303191 — intervention group
Group type: EXPERIMENTAL
Intervention: Translucent zirconia (TZ) crowns
Number of subjects: 62
Study 33303191 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LD and TZ crowns
Number of subjects: 62
Study 33303191 — intervention group
Group type: COMPARATOR
Intervention: Assessment of color match
Number of subjects: 62
Study 32916021 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic prostatectomy (RALP)
Number of subjects: 4003
Study 32916021 — intervention group
Group type: COMPARATOR
Intervention: Retropubic radical prostatectomy (RRP)
Number of subjects: 4003
Study 32916021 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon volume
Number of subjects: 4003
Study 36221988 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased fluid consumption (≥2.2 L total beverage intake, with 1.9 L being water)
Number of subjects: 13
Study 36221988 — intervention group
Group type: COMPARATOR
Intervention: Maintaining habitual fluid intake (control)
Number of subjects: 13
Study 34073918 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT‐A) injection
Number of subjects: 83
Study 34073918 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection (time between stroke onset and injection ≤90 days)
Number of subjects: 83
Study 34933568 — intervention group
Group type: EXPERIMENTAL
Intervention: REL-1017 25 mg/day
Number of subjects: 62
Study 34933568 — intervention group
Group type: EXPERIMENTAL
Intervention: REL-1017 50 mg/day
Number of subjects: 62
Study 34933568 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 32567443 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative monitoring of somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs)
Number of subjects: 48
Study 32567443 — intervention group
Group type: COMPARATOR
Intervention: No intraoperative monitoring (Control group)
Number of subjects: 48
Study 34146844 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered care intervention
Number of subjects: 152
Study 34146844 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 152